v3.26.3
SEGMENT INFORMATION - Schedule of Segment Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Financial information regarding the Company's reportable segments        
Depreciation and Amortization $ 75,544 $ 75,234 $ 230,910 $ 210,785
Capital Expenditures 69,006 63,313 191,965 183,600
Operating Segment        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 74,437 74,360 227,564 208,236
Capital Expenditures 67,887 59,665 185,339 176,915
Operating Segment | Pharma        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 35,911 35,107 110,814 100,424
Capital Expenditures 29,080 38,150 85,665 97,725
Operating Segment | Beauty        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 23,965 24,332 73,438 65,869
Capital Expenditures 24,693 12,727 63,666 44,317
Operating Segment | Closures        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 14,561 14,921 43,312 41,943
Capital Expenditures 14,114 8,788 36,008 34,873
Corporate & Other        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 1,107 874 3,346 2,549
Capital Expenditures 1,429 3,681 7,561 9,749
Transfer of Corporate Expenditures        
Financial information regarding the Company's reportable segments        
Capital Expenditures $ (310) $ (33) $ (935) $ (3,064)